DXCM Dexcom PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: DXCM
- PE Ratio
As of Jul 11, 2025, the Dexcom stock's P/E ratio is 61.76. This takes into account the latest EPS of $1.35 and stock price of $83.37. The PE ratio has increased by 18% from its last 4 quarters average of 52.2.
DXCM PE ratio history
The PE ratio of Dexcom has averaged 124.01 over the last seven years. The current price-to-earnings ratio of 61.76 is 50% less than the historical average. Analyzing the last seven years, DXCM's PE ratio reached its highest point in the Sep 2018 quarter at 298, when the price was $35.76 and the EPS was $0.12. The lowest point was recorded in the Sep 2024 quarter, when it reached 38.53 with a price of $67.04 and an EPS of $1.74.
Dexcom PE ratio by year
Maximum annual increase: 278.63% in 2021
Maximum annual decrease: -67.58% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 53.27 | -39.9% | $77.77 | $1.46 |
| 2023 | 88.64 | -31.12% | $124.09 | $1.4 |
| 2022 | 128.68 | -46.32% | $113.24 | $0.88 |
| 2021 | 239.71 | 278.63% | $134.24 | $0.56 |
| 2020 | 63.31 | -67.58% | $92.43 | $1.46 |
| 2019 | 195.3 | N/A | $54.69 | $0.28 |
| 2018 | N/A | N/A | $29.95 | -$0.36 |
| 2017 | N/A | N/A | $14.35 | -$0.15 |
| 2016 | N/A | N/A | $14.93 | -$0.2 |
| 2015 | N/A | N/A | $20.48 | -$0.18 |
| 2014 | N/A | N/A | $13.76 | -$0.08 |
| 2013 | N/A | N/A | $8.85 | -$0.11 |
| 2012 | N/A | N/A | $3.4 | -$0.2 |
| 2011 | N/A | N/A | $2.33 | -$0.17 |
| 2010 | N/A | N/A | $3.41 | -$0.24 |
Dexcom PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 50.59 | -5.03% | $68.29 | $1.35 |
| Dec 2024 | 53.27 | 38.26% | $77.77 | $1.46 |
| Sep 2024 | 38.53 | -41.89% | $67.04 | $1.74 |
| Jun 2024 | 66.3 | -21.13% | $113.38 | $1.71 |
| Mar 2024 | 84.06 | -5.17% | $138.7 | $1.65 |
| Dec 2023 | 88.64 | -6.89% | $124.09 | $1.4 |
| Sep 2023 | 95.2 | -31.1% | $93.3 | $0.98 |
| Jun 2023 | 138.18 | -9.61% | $128.51 | $0.93 |
| Mar 2023 | 152.87 | 18.8% | $116.18 | $0.76 |
| Dec 2022 | 128.68 | 0.66% | $113.24 | $0.88 |
| Sep 2022 | 127.84 | 2.91% | $80.54 | $0.63 |
| Jun 2022 | 124.22 | -34.93% | $74.53 | $0.6 |
| Mar 2022 | 190.9 | -20.36% | $127.9 | $0.67 |
| Dec 2021 | 239.71 | 192.79% | $134.24 | $0.56 |
| Sep 2021 | 81.87 | 25.01% | $136.72 | $1.67 |
DXCM Price vs fair value
DXCM average PE ratio chart
DXCM's current PE ratio is under its 3, 5 and 10-year averages.
DXCM PE vs peers
DXCM's PE ratio is above its peer stocks JNJ and ABT. Dexcom's current PE ratio of 61.76 is more than the average of its peers, which is 23.28.
| Stock name | PE ratio | Market cap |
|---|---|---|
| EW Edwards Lifesciences Corp | 11.1 | $45.78B |
| ABT Abbott Laboratories | 17.1 | $229.69B |
| JNJ Johnson & Johnson | 17.32 | $377.51B |
| MDT Medtronic plc | 24.77 | $115.21B |
| BDX Becton Dickinson & Co | 33.97 | $50.43B |
| WST West Pharmaceutical Services Inc | 35.39 | $16.32B |
| DXCM Dexcom Inc | 61.76 | $32.69B |
| TNDM Tandem Diabetes Care Inc | N/A | $1.04B |
| QDEL Quidel Corp | N/A | $2.05B |
Frequently asked questions
What is Dexcom's PE ratio?
The price to earnings ratio for DXCM stock is 61.76 as of Jul 11, 2025.
What is the 3-year average PE ratio for Dexcom (DXCM)?
As an average over the last 3 years, DXCM stock has a PE ratio of 93.11.
What is the 5-year average PE ratio for Dexcom (DXCM)?
As an average over the last 5 years, DXCM stock has a PE ratio of 105.99.
What is the highest PE ratio for DXCM?
Over the last seven years, the quarterly PE ratio reached its highest level at 298 in the Sep 2018 quarter.
How does the current PE ratio for DXCM compare to its historical average?
DXCM's price to earnings ratio is currently 50% below its 7-year historical average.
How is DXCM's PE ratio calculated (Dexcom PE ratio formula)?
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jul 11, 2025), Dexcom's share price is $83.37. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $1.35. Therefore, Dexcom's price to earnings ratio for today is 61.76. PE RATIO(61.76) = STOCK PRICE($83.37) / TTM EPS($1.35)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.